Northside Gastroenterology
Cypress, Texas, United States
Gastroenterologist in Cypress, Texas
10425 Huffmeister Rd Suite 310, Houston, TX 77065
About Northside Gastroenterology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Shire
5
Exact Sciences Corporation
1
Ironwood Pharmaceuticals, Inc.
1
Clinical Trials at Northside Gastroenterology
During the past decade, Northside Gastroenterology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on
average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
2018-02-09
2020-10-23
Terminated
380
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
2018-02-27
2023-12-31
Active, not recruiting
557
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
2018-04-04
2021-07-01
Completed
366
Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
2018-08-29
2020-10-08
Terminated
30
Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)
2018-09-06
2020-11-06
Completed
609
Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
2019-02-06
2021-09-13
Terminated
40
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
2019-01-03
2020-05-15
Completed
5,131
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Northside Gastroenterology
According to Clinical.Site data, the most researched conditions in "Northside Gastroenterology" are
"Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Colorectal Cancer" (1 trials) and "Gastroesophageal Reflux Disease (GERD)" (1 trials). Many other conditions were trialed in "Northside Gastroenterology" in a lesser frequency.
Clinical Trials Intervention Types at Northside Gastroenterology
Most popular intervention types in "Northside Gastroenterology" are "Drug" (5 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ontamalimab" (4 trials), "Placebo" (4 trials), "25 mg Ontamalimab" (1 trials), "75 mg Ontamalimab" (1 trials) and "IW-3718" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Northside Gastroenterology
The vast majority of trials in "Northside Gastroenterology" are
7 trials for "All" genders.
Clinical Trials Status at Northside Gastroenterology
Currently, there are NaN active trials in "Northside Gastroenterology".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Northside Gastroenterology,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Northside Gastroenterology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".